DK2536422T3 - Fremgangsmåder til behandling af diabetiske fodsår - Google Patents

Fremgangsmåder til behandling af diabetiske fodsår

Info

Publication number: DK2536422T3
Authority: DK; Denmark
Prior art keywords: procedures; treating diabetic; foots; diabetic foots; treating
Prior art date: 2011-02-02

Application number

DK12703408.0T

Other languages

English (en)

Inventor

Kathleen E Rodgers

Gere S Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-02

Filing date

2012-02-01

Publication date

2014-07-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45571822&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2536422(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-02-01 Application filed by Univ Southern California filed Critical Univ Southern California

2014-07-28 Application granted granted Critical

2014-07-28 Publication of DK2536422T3 publication Critical patent/DK2536422T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK12703408.0T 2011-02-02 2012-02-01 Fremgangsmåder til behandling af diabetiske fodsår DK2536422T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161438780P	2011-02-02	2011-02-02
PCT/US2012/023484 WO2012106427A2 (en)	2011-02-02	2012-02-01	Methods for treating diabetic foot ulcers

Publications (1)

Publication Number	Publication Date
DK2536422T3 true DK2536422T3 (da)	2014-07-28

Family

ID=45571822

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK12703408.0T DK2536422T3 (da)	2011-02-02	2012-02-01	Fremgangsmåder til behandling af diabetiske fodsår

Country Status (21)

Country	Link
US (3)	US8207233B1 (da)
EP (1)	EP2536422B8 (da)
JP (2)	JP5469777B2 (da)
KR (1)	KR101514414B1 (da)
CN (1)	CN102858360B (da)
AU (1)	AU2012212220B2 (da)
BR (1)	BR112013019513A2 (da)
CA (1)	CA2793515C (da)
CL (1)	CL2012002560A1 (da)
CO (1)	CO6592101A2 (da)
DK (1)	DK2536422T3 (da)
EA (1)	EA026440B1 (da)
ES (1)	ES2479765T3 (da)
HK (1)	HK1180213A1 (da)
MX (1)	MX2012010783A (da)
PE (1)	PE20130379A1 (da)
PL (1)	PL2536422T3 (da)
PT (1)	PT2536422E (da)
SG (1)	SG183960A1 (da)
WO (1)	WO2012106427A2 (da)
ZA (1)	ZA201207340B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101514414B1 (ko) *	2011-02-02	2015-05-04	유니버시티 오브 써던 캘리포니아	당뇨병성 족부 궤양의 치료방법
WO2013172956A1 (en)	2012-05-14	2013-11-21	University Of Southern California	Methods for limiting development of a skin wound
CA2884792A1 (en) *	2012-09-17	2014-03-20	Tarix Pharmaceuticals Ltd.	Oral formulations of angiotensin
US9289500B2 (en) *	2013-02-22	2016-03-22	The Regents Of The University Of California	Saccharide-peptide hydrogels
CA2911376C (en)	2013-03-15	2021-03-30	University Of Southern California	Phenyl(sulfonylcarbamate) derivatives and pharmaceutical compositions thereof for the treatment of angiotensin-related diseases
EP2968441A1 (en)	2013-03-15	2016-01-20	University of Southern California	Methods for treating multiple sclerosis
US9981011B2 (en) *	2014-03-10	2018-05-29	Rush University Medical Center	Methods of promotion of healing of diabetic wounds
WO2016108130A1 (en) *	2014-12-30	2016-07-07	Sun Pharmaceutical Industries Limited	Topical pharmaceutical compositions comprising nebivolol for the treatment of diabetic wounds
US20180344680A1 (en) *	2015-12-08	2018-12-06	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Compositions and methods for treatment, amelioration, and prevention of diabetes-related skin ulcers
WO2021072225A1 (en) *	2019-10-09	2021-04-15	Rush University Medical Center	Modulating interleukin-10 signaling to boost healing in diabetic wounds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015629A (en)	1989-06-26	1991-05-14	University Of Southern California	Tissue repair
WO1993008825A1 (en) *	1991-11-04	1993-05-13	Zymogenetics, Inc.	Pdgf gel formulation
US5955430A (en)	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
DE69435301D1 (de)	1993-09-24	2010-08-26	Univ Southern California	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
DE69429450T2 (de)	1993-09-24	2002-07-25	University Of Southern California, Los Angeles	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
US5834432A (en)	1995-06-06	1998-11-10	The University Of Southern California	Use of angiotensin II Type 2 receptor agonists in tissue repair
US6110895A (en)	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en)	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
DE69824445T2 (de)	1997-12-12	2005-06-30	University Of Southern California, Los Angeles	Zusammensetzungen zur wundheilung
AU2593599A (en)	1998-02-09	1999-08-23	University Of Southern California	Method of promoting keratinocyte proliferation
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6498138B1 (en)	1998-03-11	2002-12-24	University Of Southern California	Method of promoting production of living tissue equivalents
JP2003521441A (ja)	1998-05-11	2003-07-15	ユニヴァースティオブサザーンカリフォルニア	化学療法後の白血球生残率を増加させる方法
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
CA2328871C (en)	1998-07-13	2002-10-01	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
JP2002522505A (ja)	1998-08-13	2002-07-23	ユニヴァースティオブサザーンカリフォルニア	虚血組織への血流を増加させる方法
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
AU1792901A (en)	1999-12-16	2001-06-25	University Of Southern California	Methods for treating and preventing diabetic complications
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
AU2001218024A1 (en) *	2000-06-19	2002-01-02	University Of Southern California	Methods for treating and preventing alopecia
US20060058238A1 (en) *	2004-09-15	2006-03-16	Lee Laurent-Applegate	Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
EP2245061A2 (en) *	2007-12-11	2010-11-03	Coda Therapeutics, Inc.	Impaired wound healing compositions and treatments
US20090227507A1 (en)	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
US9272013B2 (en)	2010-03-26	2016-03-01	University Of Southern California	Methods for treating combined radiation and thermal injury
US20120071397A1 (en)	2010-08-10	2012-03-22	University Of Southern California	Methods for Hematopoietic Stem Cell Transplantation
KR101514414B1 (ko) *	2011-02-02	2015-05-04	유니버시티 오브 써던 캘리포니아	당뇨병성 족부 궤양의 치료방법

2012
- 2012-02-01 KR KR1020127023804A patent/KR101514414B1/ko active IP Right Grant
- 2012-02-01 EP EP12703408.0A patent/EP2536422B8/en active Active
- 2012-02-01 CA CA2793515A patent/CA2793515C/en active Active
- 2012-02-01 PT PT127034080T patent/PT2536422E/pt unknown
- 2012-02-01 PL PL12703408T patent/PL2536422T3/pl unknown
- 2012-02-01 JP JP2013502927A patent/JP5469777B2/ja active Active
- 2012-02-01 EA EA201201296A patent/EA026440B1/ru not_active IP Right Cessation
- 2012-02-01 SG SG2012066452A patent/SG183960A1/en unknown
- 2012-02-01 ES ES12703408.0T patent/ES2479765T3/es active Active
- 2012-02-01 DK DK12703408.0T patent/DK2536422T3/da active
- 2012-02-01 PE PE2012001812A patent/PE20130379A1/es not_active Application Discontinuation
- 2012-02-01 AU AU2012212220A patent/AU2012212220B2/en active Active
- 2012-02-01 CN CN201280001085.4A patent/CN102858360B/zh active Active
- 2012-02-01 MX MX2012010783A patent/MX2012010783A/es active IP Right Grant
- 2012-02-01 WO PCT/US2012/023484 patent/WO2012106427A2/en active Application Filing
- 2012-02-01 US US13/364,061 patent/US8207233B1/en active Active
- 2012-02-01 BR BR112013019513A patent/BR112013019513A2/pt not_active Application Discontinuation
- 2012-04-06 US US13/441,653 patent/US8207234B1/en active Active
- 2012-05-09 US US13/467,253 patent/US8536231B2/en active Active
- 2012-09-10 CO CO12154938A patent/CO6592101A2/es unknown
- 2012-09-14 CL CL2012002560A patent/CL2012002560A1/es unknown
- 2012-10-01 ZA ZA2012/07340A patent/ZA201207340B/en unknown
2013
- 2013-06-25 HK HK13107412.0A patent/HK1180213A1/xx unknown
- 2013-12-19 JP JP2013262634A patent/JP2014080425A/ja active Pending

Also Published As

Publication number	Publication date
ZA201207340B (en)	2013-02-27
PT2536422E (pt)	2014-07-18
WO2012106427A2 (en)	2012-08-09
JP2013523781A (ja)	2013-06-17
US8207233B1 (en)	2012-06-26
KR20120137365A (ko)	2012-12-20
US8536231B2 (en)	2013-09-17
JP5469777B2 (ja)	2014-04-16
WO2012106427A3 (en)	2012-09-20
CO6592101A2 (es)	2013-01-02
KR101514414B1 (ko)	2015-05-04
CA2793515C (en)	2015-05-12
AU2012212220A1 (en)	2012-10-18
EA201201296A1 (ru)	2013-02-28
ES2479765T3 (es)	2014-07-24
US8207234B1 (en)	2012-06-26
EA026440B1 (ru)	2017-04-28
EP2536422B1 (en)	2014-04-30
CA2793515A1 (en)	2012-08-09
CN102858360A (zh)	2013-01-02
MX2012010783A (es)	2012-11-23
BR112013019513A2 (pt)	2019-06-11
EP2536422B8 (en)	2023-06-21
JP2014080425A (ja)	2014-05-08
CL2012002560A1 (es)	2013-03-22
PL2536422T3 (pl)	2014-09-30
HK1180213A1 (en)	2013-10-18
AU2012212220B2 (en)	2013-04-04
US20120329729A1 (en)	2012-12-27
PE20130379A1 (es)	2013-04-13
SG183960A1 (en)	2012-10-30
EP2536422A2 (en)	2012-12-26
CN102858360B (zh)	2017-07-25

Publication	Publication Date	Title
DK3225604T3 (da)	2019-06-17	Fremgangsmåde til fremstilling af flerlagsruder
DK2709613T4 (da)	2020-11-16	Fremgangsmåder til behandling af hcv
DK2914965T3 (da)	2021-04-26	Aflukker til biologiske mikroobjekter
DK3520805T3 (da)	2021-04-19	Sammensætninger til behandling af myelofibrose
DK2536422T3 (da)	2014-07-28	Fremgangsmåder til behandling af diabetiske fodsår
BR112013033332A2 (pt)	2017-01-31	calçado
BR112014007958A2 (pt)	2017-04-11	método
BR112014012016A2 (pt)	2017-05-16	compostos
BR112014001237A2 (pt)	2017-02-21	método
DK2708147T3 (da)	2020-05-18	Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
DK2857019T3 (da)	2020-08-17	Fremgangsmåde til behandling af multipel sklerose
BR112014001851A2 (pt)	2017-02-21	método
UY4109Q (es)	2011-12-01	Calzado
BR112014009795A2 (pt)	2017-04-25	método
BR112013022820A2 (pt)	2016-12-06	método de tratamento
DK2849760T3 (da)	2020-02-03	Fremgangsmåder til oligonukleotid-chelatkompleks
DK2870252T3 (da)	2020-03-16	Fremgangsmåder ved anvendelse af patatin
DK2834229T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af ccr3-inhibitorer
DK2872536T3 (da)	2019-11-25	Fremgangsmåde til ekstraktion af biomasse
DK2916661T3 (da)	2019-06-03	Fremgangsmåde til opnåelse af bloom-hæmmende komponenter til konfektureprodukter
DK2489276T3 (da)	2014-01-20	Fremgangsmåde til udvinding af olie
DK2788353T3 (da)	2022-08-15	Bur-aminligander til metallo-radiofarmaceutika
DK2701707T3 (da)	2020-11-02	Fremgangsmåde til behandling af dyskinesi
BR112013023606A2 (pt)	2016-12-06	mwdidor de dorante automático
DK2808346T3 (da)	2019-05-20	Fremgangsmåde til fremstilling af tørret biocellulose